New Zealand's Ministry of Health has announced it is prosecuting Promisia, the manufacturer of arthritis supplement Arthrem, in a move the firm's CEO claims is littered with "significant factual errors".
Pharmaceutical firms are making strides in the Australia's medical cannabis space, but supplement and nutraceutical firms will have to wait a long time before they can do the same, says an industry expert.
New Zealand’s natural products sector is facing yet another lengthy process of workshops, surveys and consultations to secure regulations that are fit-for-purpose, after the government signalled its intention to go back to the drawing board.
Australian medical R&D facility Medlab Clinical will see its nutraceutical product range sold at Priceline Pharmacy, one of the country's largest pharmacy groups, thanks to a deal with Australian Pharmaceutical Industries (API).
Marinova has commenced a clinical trial to investigate the gut health benefits of its bioactive seaweed extract, Maritech fucoidan, on elite athletes, with the broader goal of entering the sports nutrition market.
GOED (the Global Organization for EPA and DHA) is disputing the results of an Australian study that claims that excessive oxidation is compromising the health benefits of fish oil supplements sold in Australasia.